Business, News Iconic Therapeutics Initiates Second Phase 2 Study of ICON-1 in Patients With Neovascular (wet) AMD by Business Wire • 2018/05/16 • 0 Comments SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--ICONIC starts second Phase 2 study Full Story →